Drugs acting as plasticizers in polymeric systems a quantitative treatment.pdf

download Drugs acting as plasticizers in polymeric systems a quantitative treatment.pdf

of 9

Transcript of Drugs acting as plasticizers in polymeric systems a quantitative treatment.pdf

  • 7/30/2019 Drugs acting as plasticizers in polymeric systems a quantitative treatment.pdf

    1/9

    Drugs acting as plasticizers in polymeric systems: A quantitative treatment

    F. Siepmann a, b, V. Le Brun a, J. Siepmann a,b,

    a College of Pharmacy, Freie Universitaet Berlin, Kelchstr. 31, 12169 Berlin, Germanyb College of Pharmacy, JE 2491, University of Lille, 3 Rue du Professeur Laguesse, 59006 Lille, France

    Received 7 July 2006; accepted 25 August 2006

    Available online 1 September 2006

    Abstract

    The objective of the present study was to investigate and quantify the effects of ibuprofen, chlorpheniramine maleate and metoprolol tartrate on

    the thermal, mechanical and diffusional properties of polyacrylate-based films. Thin drug-containing films were prepared from organic Eudragit

    RS solutions and physicochemically characterized with respect to their glass transition temperature, mechanical properties and drug release

    kinetics in phosphate buffer pH 7.4. The apparent diffusion coefficient of the drug within the polymeric systems was determined by fitting an

    adequate solution of Fick's second law of diffusion to the experimentally determined release profiles. Importantly, the glass transition temperature

    of the films significantly decreased with increasing initial drug content, whereas the film flexibility and drug release rate increased. This clearly

    indicates that the three drugs act as efficient plasticizers for Eudragit RS. Interestingly, the mathematical analysis revealed that drug release was

    primarily controlled by diffusion. An increase in the initial drug content resulted in increased drug diffusivities and, thus, accelerated (absolute and

    relative) drug release rates. Importantly, quantitative relationships could be established between the drug diffusivity and the initial drug content.

    Based on this knowledge, the effects of the films' composition and thickness on the resulting drug release kinetics (also from coated solid dosage

    forms) can be predicted in a quantitative way.

    2006 Elsevier B.V. All rights reserved.

    Keywords: Plasticizer; Diffusion; Release mechanism; Mathematical modeling; Eudragit RS

    1. Introduction

    Polymers are frequently used to control drug release from

    pharmaceutical devices. For example, solid dosage forms can be

    coated with thin polymeric films [1,2]. However, pure polymer

    coatings are often brittle and poorly permeable for many drugs.

    To overcome these restrictions, external plasticizers are

    frequently added to the polymeric networks. They increase

    the flexibility of the coatings, increase the permeability for the

    drug and promote film formation (in the case of aqueouspolymer dispersions). The extent of plasticization depends

    largely on the amount of added plasticizer and on the type of

    plasticizerpolymer interactions [3]. For example, Gutierrez-

    Rocca and McGinity [4] studied the effects of water-soluble and

    insoluble plasticizers on the physical and mechanical properties

    of acrylic resin copolymers. Of the investigated plasticizers,

    triacetin had the most pronounced effect on the flexibility of the

    polymeric systems, followed by triethyl citrate. These differ-

    ences in plasticizing efficiency were attributed to differences in

    molecular size and ability to interact with the macromolecules.

    It has to be pointed out that in addition to the classical

    plasticizers also other film components (e.g., certain

    preservatives and surfactants) can significantly affect the

    properties of the polymeric systems. Several studies report the

    plasticization of polymers by non-classical plasticizers. For

    instance, Frisbee and McGinity [5] studied the influence ofdifferent types of non-ionic surfactants on the physical and

    chemical properties of a biodegradable pseudolatex based on

    poly(DL-lactic acid) (PLA). Pluronic F68 was shown to

    effectively reduce the glass transition temperature (Tg) of

    PLA. O'Donnell et al. [6] reported plasticization effects of the

    preservatives methylparaben and propylparaben on the natural

    polymer zein. Methylparaben was also reported to plasticize

    other polymers, including acrylic copolymers (Eudragit RS and

    Eudragit RL) [7].

    Importantly, also drugs can act as plasticizers for polymeric

    systems, resulting in significant changes in the thermo-

    Journal of Controlled Release 115 (2006) 298306

    www.elsevier.com/locate/jconrel

    Corresponding author. College of Pharmacy, JE 2491, University of Lille,

    3 Rue du Professeur Laguesse, 59006 Lille, France. Tel.: +33 3 20964708;

    fax: +33 3 20964942.

    E-mail address: [email protected](J. Siepmann).

    0168-3659/$ - see front matter 2006 Elsevier B.V. All rights reserved.doi:10.1016/j.jconrel.2006.08.016

    mailto:[email protected]://dx.doi.org/10.1016/j.jconrel.2006.08.016http://dx.doi.org/10.1016/j.jconrel.2006.08.016mailto:[email protected]
  • 7/30/2019 Drugs acting as plasticizers in polymeric systems a quantitative treatment.pdf

    2/9

    mechanical properties of film coatings and drug release profiles.

    Aitken-Nichol et al. [8] prepared Eudragit E100-based films

    loaded with lidocaine HCl and characterized them physico-

    chemically. It was shown that an increase in the drug content led

    to a significant decrease in the glass transition temperature (Tg)

    of the polymer and an increase in elongation at break of the

    films, indicating that this drug acts as an efficient plasticizer forthis polymer. Furthermore, Crowley et al. [9] demonstrated the

    plasticizing ability of ketoprofen for poly(ethylene oxide). The

    addition of 15% ketoprofen resulted in a more than two-fold

    increase in % elongation of the films (compared to drug-free

    systems), and the tensile strength was shown to significantly

    decrease with increasing ketoprofen content. McGinity and co-

    workers [1013] showed that chlorpheniramine maleate and

    ibuprofen are efficient plasticizers for acrylic copolymers. For

    instance, the addition of chlorpheniramine maleate to Eudragit

    RS and Eudragit RL-based films resulted in a decrease of the Tgof the polymers [10]. This effect can be very advantageous: For

    example, it allows to lower the processing temperature duringthe hot-melt extrusion of tablets [11]. Wu and McGinity [12]

    investigated the influence of ibuprofen and chlorpheniramine

    maleate on the thermal and mechanical properties of polymeric

    films prepared from aqueous dispersions of Eudragit RS30D. In

    addition, drug release from pellets coated with drug-containing

    dispersions was studied. Both, ibuprofen and chlorpheniramine

    maleate were found to decrease the tensile strength of the

    polymeric films and the Young's modulus of the coated pellets.

    Importantly, the release rate decreased with increasing drug

    level in the polymeric film coating, indicating an increasing

    degree of coalescence between the latex particles (a phenom-

    enon which is also observed with increasing levels of classical

    plasticizers). Scanning electron microscopy pictures of pelletscoated with ibuprofen-containing Eudragit RS30D dispersions

    confirmed this hypothesis [13]. An increase in the drug content

    of the film coatings resulted in smoother film surfaces. Fourier

    Transform Infrared Spectroscopy (FTIR) revealed that ibupro-

    fen interacts via hydrogen bonding with the acrylic copolymer.

    Different techniques can be used to investigate the

    plasticizing efficiency of a substance for a particular polymeric

    system, including the measurement of the tensile strength and %

    film elongation at break, glass transition temperature (Tg) and

    intrinsic viscosity of polymer solutions. However, so far only

    little is known on the effects of a plasticizer on the mobility of a

    drug in a polymeric system in a quantitative way. Thisknowledge is of fundamental importance, in particular for

    controlled drug delivery systems. In general, diffusional mass

    transport plays a major role for the control of drug release. Thus,

    a better understanding of the effects of a plasticizer on drug

    mobility in polymeric systems can be very helpful to facilitate

    device optimization. This is especially true if the drug itself acts

    as a plasticizer. Different techniques have been described to

    experimentally determine diffusion coefficients in polymers.

    Importantly, once the diffusivity is known, drug release can be

    predicted in a quantitative way [14,15]. A comprehensive

    review of adequate mathematical models has been given by Fan

    and Singh [16]. To adjust desired drug release rates, the

    diffusion coefficient of the drug in the polymeric system (e.g.,

    film coating) can be varied. In general, different types and

    amounts of classical plasticizers are added. Siepmann et al. [3]

    presented a quantitative treatment of the effects of acetyltributyl

    citrate, acetyltriethyl citrate, dibutyl phthalate, dibutyl sebacate,

    diethyl phthalate, and tributyl citrate on drug mobility in

    ethylcellulose-based systems. However, yet very little is known

    on the importance of non-classical plasticizers (in particulardrugs) for the resulting release kinetics.

    The objectives of the present study were: (i) to investigate

    the effects of chlorpheniramine maleate, ibuprofen and

    metoprolol tartrate on the properties of polyacrylate-based

    films; (ii) to use an adequate mathematical theory to determine

    the apparent diffusion coefficients of the drugs within the

    polymeric systems; (iii) to establish quantitative relationships

    between the composition of the device and the resulting release

    rates; (iv) to better understand the importance of the plasticizing

    effects of drugs in polymeric controlled drug delivery systems;

    and (v) to be able to quantitatively predict the effects of different

    formulation and processing parameters on the resulting drugrelease profiles.

    2. Materials

    Chlorpheniramine maleate (Sigma Chemical Co., St Louis,

    MO, USA), ibuprofen (Salutas Pharma GmbH, Barleben,

    Germany), metoprolol tartrate (BASF, Ludwigshafen, Ger-

    many), poly(ethylacrylate methylmethacrylate trimethylammo-

    nioethyl methacrylate chloride 1:2:0.1) (Eudragit RS PO;

    Roehm, Darmstadt, Germany) were used as received.

    3. Experimental methods

    3.1. Preparation of thin, polymeric films

    Thin, drug-containing films were prepared by casting etha-

    nolic drug-Eudragit RS solutions onto Teflon plates using a

    casting knife (Multicator 411; Erichsen, Hemer, Germany). The

    drug loading was varied from 7.5% to 30% (w/w, based on the

    polymer mass). The subsequent drying process was standard-

    ized as follows: 1 day at room temperature, 1 day at 40 C, and

    1 day at room temperature. The thickness of the films (80

    120 m) was measured using a thickness gauge (Minitest 600;

    Erichsen, Hemer, Germany). All films were clear (visual

    observation), indicating that the drug was molecularly dispersedwithin the system. Thin, drug-free polymeric films were

    prepared accordingly.

    3.2. Drug release studies

    Thin, polymeric films were cut into pieces of 55 cm, which

    were placed into plastic containers filled with 150 ml pre-heated

    phosphate buffer pH 7.4 (USP XXVII), followed by horizontal

    shaking (37 C, 75 rpm; GFL 3033; Gesellschaft fr

    Labortechnik, Burgwedel, Germany). At pre-determined time

    intervals, samples were withdrawn and analyzed UV-spectro-

    photometrically (=262, 275 and 222 nm for chlorpheniramine

    maleate, ibuprofen and metoprolol tartrate, respectively) (UV-

    299F. Siepmann et al. / Journal of Controlled Release 115 (2 006) 298306

  • 7/30/2019 Drugs acting as plasticizers in polymeric systems a quantitative treatment.pdf

    3/9

    2101 PC; Shimadzu Scientific Instruments, Columbia, MD,

    USA).

    3.3. Thermal analysis

    The glass transition temperature (Tg) of the polymeric

    systems was determined by differential scanning calorimetry(DSC 821; Mettler Toledo AG, Giessen, Germany). Film

    samples of approximately 6 mg were accurately weighed into

    aluminum pans, which were sealed and perforated. The samples

    were heated (at 5 C/min) under a nitrogen atmosphere from 0

    to 100 C, then cooled to 0 C (at40 C/min), and re-heated to

    100 C (at 5 C/min). The glass transition temperature was

    determined from the second heating cycle.

    3.4. Mechanical properties of thin, polymeric films

    Thin films were characterized using the puncture test and a

    texture analyzer (TA.XT Plus; Swantech, Gennevilliers,France). Film specimens were mounted on a film holder. The

    puncture probe (spherical end: 5 mm diameter) was fixed on the

    load cell (5 kg) and driven downward with a cross-head speed of

    0.1 mm/s to the center of the film holder's hole. Load versus

    displacement curves were recorded until rupture of the films and

    used to determine the puncture strength and % elongation at

    break as follows:

    puncture strength FA

    1

    where F is the load required to puncture the film and A is the

    cross-sectional area of the edge of the film located in the path.

    elongationat break % ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi

    R2 d2p RR

    d100% 2

    where R denotes the radius of the film exposed in the cylindrical

    hole of the holder and d is the displacement to puncture.

    4. Theoretical methods

    The apparent diffusion coefficient of the drugs within the

    polymeric systems were determined by fitting an analytical

    solution of Fick's second law of diffusion to the experimentally

    determined drug release kinetics from thin polymeric films, inwhich the drugs were molecularly dispersed (monolithic

    solutions). As the surface of the films was very large compared

    to their thickness (approximately 50 cm2 versus 100 m), edge

    effects were negligible and the mathematical analysis could be

    restricted to one dimension. Hence, the release kinetics can be

    described by Fick's second law of diffusion in a plane sheet

    [14]:

    Ac

    At DdA

    2c

    Ax23

    where c denotes the concentration of the drug within the

    polymeric system, being a function of the time tand position x.

    The initial condition for this partial differential equation is as

    follows, expressing the fact that the drug is uniformly

    distributed throughout the film at the beginning of the

    experiment:

    t 0 c cini LV xVL 4Here, cini represents the initial drug concentration in the

    system and L is the half-thickness of the film. The drug

    concentration far away from the surface of the film is assumed

    to be constant and equal to zero because the release medium is

    well stirred and perfect sink conditions are maintained during

    the experiments. Near to the surface of the film an unstirred

    liquid layer is considered (even in well-agitated systems thin

    unstirred layers exist, leading to an additional mass transfer

    resistance). As there is no accumulation of the drug on the

    surface of the film, the rate at which the drug is transported to

    the surface by diffusion through the film is always equal to the

    rate at which it leaves the film. This rate, per unit area, is

    proportional to the difference of the actual concentration on thesurface (csur) and the concentration required to maintain

    equilibrium with the surrounding environment (c

    ). The

    constant of proportionality is called the mass transfer coefficient

    in the boundary layer (h). As the thickness of the boundary layer

    essentially depends on the rate of stirring, h is a function of the

    stirring rate. This boundary condition is mathematically

    expressed as:

    tN0 DdjAcAxj

    xFL hd csurcl 5

    This initial value problem (Eqs. (3)(5)) can be solved using

    the method of Laplace transform, leading to [17,18]:

    Mt

    Ml

    1Xln1

    2dG2

    b2nd b2n G2 Gdexp

    b2nL2

    dDd t

    6

    where the n's are the positive roots of:

    bd tan b G 7with

    G LdhD

    8

    Here, Mt and M are the cumulative amounts of drugreleased at time t and t=, respectively; G denotes a

    dimensionless constant.

    The diffusion coefficient of the drug (D) and the mass

    transfer coefficient in the boundary layer (h) were determined

    by fitting this set of equations (Eqs. (6)(8)) to experimentally

    measured in vitro drug release kinetics.

    5. Results and discussion

    5.1. Thermal and mechanical properties of polymeric films

    The presence of an (external) plasticizer within a polymeric

    system decreases the attractive forces between the macromolecules,

    300 F. Siepmann et al. / Journal of Controlled Release 115 (2006) 298306

  • 7/30/2019 Drugs acting as plasticizers in polymeric systems a quantitative treatment.pdf

    4/9

    resulting in increased macromolecular mobilities. Consequently,the temperature at which an (amorphous) polymer undergoes the

    transition from the glassyto the rubbery state (and vice versa) (Tg)

    decreases. The extent to which the Tg is lowered is an important

    measure for the efficiency of the plasticizer [11,12,19]. Fig. 1

    illustrates the effects of chlorpheniramine maleate, ibuprofen and

    metoprolol tartrate on the glass transition temperature of Eudragit

    RS films. Clearly, the Tg significantly decreased with increasing

    drug loading, irrespective of the type of drug. This indicates that

    all three drugs act as plasticizers for the acrylic polymer, withibuprofen showing the most pronounced effect, followed by

    chlorpheniramine maleate and metoprolol tartrate.

    Changes in the mechanical properties of the polymeric films

    confirmed this observation. The puncture strength and %

    elongation at break significantly increased with increasing drug

    loading (Fig. 2). Moreover, the ranking order of the three drugs

    with respect to their plasticizing ability monitored as increase in

    % elongation (Fig. 2b) and decrease in Tg (Fig. 1) is the same:

    ibuprofenNchlorpheniramine maleateNmetoprolol tartrate. In-

    terestingly, ibuprofen films showed a decrease in puncture

    strength above initial loadings of 20% (w/w). This can be

    explained by the decrease of the glass transition temperature ofthe polymeric ibuprofen-loaded films below room temperature

    (at which the experiments were performed) (Fig. 1). Conse-

    quently, the polymer undergoes the transition from the glassy to

    the rubbery state, resulting in a decrease in puncture strength. In

    contrast, Eudragit RS films containing chlorpheniramine

    maleate and metoprolol tartrate remained in the glassy state in

    the investigated range of drug loadings. Thus, their puncture

    strength monotonically increased with increasing drug content

    (Fig. 2a).

    5.2. Drug release from thin films

    As an example, Fig. 3 shows the release of metoprololtartrate from Eudragit RS films in phosphate buffer pH 7.4

    (symbols= experimentally measured kinetics). Clearly, the

    release rate was high at the beginning and then monotonically

    decreased with time. This is a typical behavior for diffusion

    controlled drug delivery systems: With increasing time the

    length of the diffusion pathways increases. Thus, the drug

    Fig. 2. Effects of the drug loading (% w/w) on the (a) puncture strength, (b) %

    elongation at break of Eudragit RS films. The type of drug is indicated in thefigure.

    Fig. 1. Effects of the drug loading (% w/w) on the glass transition temperature

    (Tg) of Eudragit RS films. The type of drug is indicated in the figure.

    Fig. 3. Experiment (symbols) and theory (Eqs. (6)(8), curve): Metoprolol

    tartrate release from Eudragit RS films in phosphate buffer pH 7.4 (10%w/w drug loading; 83 m film thickness).

    301F. Siepmann et al. / Journal of Controlled Release 115 (2 006) 298306

  • 7/30/2019 Drugs acting as plasticizers in polymeric systems a quantitative treatment.pdf

    5/9

    concentration gradients (the driving forces for diffusion)

    decrease and, consequently, the drug release rate decreases.

    To better understand the underlying mass transport mechan-

    isms, the presented analytical solution of Fick's second law of

    diffusion (Eqs. (6)(8)) was fitted to the experimentally

    measured drug release kinetics (Fig. 3: curve). This mathemat-

    ical model considers an initial homogeneous drug distribution att=0 (before exposure to the release medium), an initial drug

    concentration lower than drug solubility (monolithic solution),

    perfect sink conditions and the presence of a thin liquid

    unstirred layer surrounding the film. This boundary layer causes

    an additional resistance for drug release, which can be

    characterized by the so-called mass transfer coefficient, h.

    Importantly, good agreement between theory and experiment

    was observed (Fig. 3: curve and symbols) (coefficient of

    determination R2 =1.00; only one example is shown, the

    agreement being similar for the other polymeric films). This

    clearly indicates that drug release was primarily controlled by

    pure diffusion. Interestingly, h was found to be very high in allcases, resulting in a high dimensionless numberG=Lh/DN100.

    This reveals that the mass transfer resistance within the

    boundary layer on the surface of the films is negligible

    compared to the mass transfer resistance within the polymeric

    systems in the present study. Thus, also the following,

    simplified analytical solution of Fick's second law of diffusion

    considering drug transport from thin films (with initial drug

    concentrations lower than drug solubility and initial homoge-

    neous drug distributions) into perfect sink conditions can be

    used to quantify drug release:

    Mt

    Ml

    1Xl

    n0

    8

    2dn 12p2 dexp 2dn

    1

    2dp2

    4dL2 dDd t !

    9where Mt and M are the cumulative amounts of drug released

    at time t and t=; D denotes the diffusion coefficient of the

    drug and L is the half-thickness of the polymeric film. Fitting

    Eq. (9) to the experimentally determined drug release kinetics

    shown in Fig. 3 resulted in a curve (not shown) which overlaps

    with the illustrated curve (obtained by fitting Eqs. (6)(8)). The

    determined diffusion coefficients were equal (in this example:

    D =3.8109 cm2/s). Thus, both the complex and the

    simplified mathematical theory (Eqs. (6) (7) (8) and (9),

    respectively) can be used to determine the apparent drugdiffusivities in the investigated polymeric films. In the

    following, the fittings with more complex mathematical

    model (Eqs. (6)(8)) are shown, because the negligibility of

    the mass transfer resistance within the liquid unstirred boundary

    layer had to be proven.

    To be able to judge the reproducibility of the experimentally

    determined drug release kinetics, each film was prepared in

    triplicate. Fig. 4a shows as an example metoprolol tartrate

    release from three films of identical composition, but prepared

    at three different days (experimental results: symbols). As slight

    variations in the film thickness are difficult to avoid (the films

    were prepared by casting), the resulting drug release rates

    slightly differ: With increasing film thickness the relative drug

    release rate decreased. This can be explained by the increase in

    the length of the diffusion pathways. Fitting (Eqs. (6)(8)) to

    the drug release kinetics resulted in good agreement between

    theory and experiment in all cases (Fig. 4a). Based on these

    calculations, the diffusivity of metoprolol tartrate in Eudragit

    RS-based films with an initial drug content of 10% (w/w) wasdetermined to be equal to 3.7 (0.3)109 cm2/s. Thus, the

    reproducibility of this technique to determine drug diffusion

    coefficients in the investigated polymers is good. To be able to

    directly compare the drug release patterns from polymeric films

    with slightly different thickness, the results can be normalized:

    According to Eq. (9), the time can for instance be divided by

    (2L)2. Fig. 4b shows the normalized drug release kinetics from

    the three films in phosphate buffer pH 7.4. Clearly, all three

    curves are overlapping. In the following, generally normalized

    relative drug release rates are shown to account for the slight,

    arbitrary variations in film thickness.

    Importantly, the relative drug release rate from the polymeric

    films increased with increasing initial drug loading. Fig. 5 shows

    Fig. 4. Metoprolol tartrate release from Eudragit RS films (10% w/w drug

    loading): (a) non-normalized data; (b) normalized data (to the film thickness).

    Results obtained with three different films of identical composition, but different

    thickness (indicated in the figures) are shown. Experiment (symbols) and theory

    (Eqs. (6)(8), curves).

    302 F. Siepmann et al. / Journal of Controlled Release 115 (2006) 298306

  • 7/30/2019 Drugs acting as plasticizers in polymeric systems a quantitative treatment.pdf

    6/9

    the results obtained with (a) metoprolol tartrate, (b) chlorphenir-

    amine maleate and (c) ibuprofen. As it can be seen, good

    agreement between theory (Eqs. (6)(8)) and experiments

    (symbols) was obtained in all cases. Based on these fittings,

    the apparent diffusion coefficients of the drugs in the

    investigated polymeric systems could be determined. Fig. 6

    shows the significant increase in drug diffusivity in Eudragit RS

    with increasing initial drug content. This is a further, clear

    indication for the plasticizing effects of ibuprofen, chlorphenir-

    amine maleate and metoprolol tartrate on Eudragit RS. Thepresence of the drug in the polymeric systems increases the

    mobility of the macromolecules and, thus, the free volume

    available for diffusion. Interestingly, the following quantitative

    relationships between the diffusion coefficient of the drugs, D,

    and the initial drug loading (wd, in % w/w) could be established

    (curves in Fig. 6):

    D 0:921d exp0:142dwdd109cm2=s; R2 0:98 10

    D 0:407d exp0:079dwdd109cm2=s; R2 0:97 11

    D 0:008d exp0:073dwdd109cm2=s; R2 0:98 12for metoprolol tartrate, chlorpheniramine maleate and ibuprofen,

    respectively. Thus, the mobility of the drug increases exponen-

    tially with its initial loading. This is in good agreement with the

    effects of conventional plasticizers. For example, it was shown

    that the diffusion coefficient of theophylline in ethyl cellulose

    increases exponentially with the initial content of acetyltributyl

    citrate [3].

    To be able to compare the release kinetics of the three drugs

    from the investigated Eudragit RS-based films, the results ob-

    tained with systems of identical initial drug content (20% w/w)

    were compared (Fig. 7). Clearly, metoprolol tartrate release was

    much faster than that of chlorpheniramine maleate andibuprofen, the diffusion coefficients being equal to 136, 16

    and 0.361010 cm2/s, respectively. As perfect sink conditions

    were maintained throughout the release experiments and as the

    drugs were molecularly dispersed within the polymeric

    Fig. 5. Effects of the initial drug loading (% w/w, indicated in the figures) on the

    release patterns from Eudragit RS films in phosphate buffer pH 7.4: (a)

    metoprolol tartrate, (b) chlorpheniramine maleate, and (c) ibuprofen. Experi-

    ments (symbols) and theory (Eqs. (6)(8), curves).

    Fig. 6. Effects of the initial drug loading on the diffusion coefficient of the drug

    in Eudragit RS films (the type of drug is indicatedin the figure). Symbols: values

    determined from the fittings shown in Fig. 5, curves: exponential relationships

    according to Eqs. (10)

    (12). The blow up is a zoom on the results obtained withibuprofen.

    303F. Siepmann et al. / Journal of Controlled Release 115 (2 006) 298306

  • 7/30/2019 Drugs acting as plasticizers in polymeric systems a quantitative treatment.pdf

    7/9

    networks (monolithic solutions), the drug solubilities in

    phosphate buffer pH 7.4 (5, 331, and 10 000 mg/ml for

    ibuprofen, chlorpheniramine maleate and metoprolol tartrate,

    respectively) cannot explain the observed differences in the

    release kinetics. But electrostatic interactions between the drugs

    and the polymer can be expected to play a major role. In contrast

    to metoprolol and chlorpheniramine, ibuprofen is negatively

    charged at pH 7.4 and can, thus, interact with the positively

    charged quaternary ammonium groups of Eudragit RS.

    Consequently, drug diffusion is significantly hindered. This

    ionic interaction is in good agreement with the observed marked

    decrease in the glass transition temperature of ibuprofen-Eudragit RS systems (Fig. 1). In contrast, electrostatic

    interactions are unlikely with the two other drugs. Remark:

    More complex mathematical models, considering desorption as

    well as diffusion mechanisms (e.g., [20]) can be used to analyze

    these phenomena in more detail. However, such an analysis

    requires more comprehensive experimental results and was

    beyond the scope of this study. The determined diffusion

    coefficients are apparent diffusivities.

    Fig. 7. Effects of the type of drug (indicated in the figure) on the release patterns

    from Eudragit RS films in phosphate buffer pH 7.4 (20% w/w initial drug

    loading; normalized data).

    Fig. 8. Theoretical prediction (Eqs. (6)(8), curve) and experimental verification

    (symbols): Ibuprofen release from Eudragit RS films in phosphate buffer pH 7.4(12.5%w/w initial drug loading; film thickness=112m;D =1.91011 cm2/s).

    Fig. 9. Theoretical prediction of the effects of (a) the film thickness (indicated in

    the figure) on chlorpheniramine maleate release fromEudragit RS films (15% w/

    w initial drug loading), (b) the initial drug loading (% w/w, indicated in the

    figure) on chlorpheniramine maleate release (film thickness: 40 m), and (c) the

    type of drug and film thickness (indicated in the figure) on the release patterns

    from Eudragit RS films (5% w/w initial drug loading).

    304 F. Siepmann et al. / Journal of Controlled Release 115 (2006) 298306

  • 7/30/2019 Drugs acting as plasticizers in polymeric systems a quantitative treatment.pdf

    8/9

    It has to be pointed out that salts of metoprolol and chlor-

    pheniramine were studied and that the respective counterions

    can be expected to interact with the polymer. Narisawa et al.

    [21,22] showed that several organic acids (including malic and

    tartaric acid=the protonated forms of the counterions used in

    this study) significantly increase the permeability of Eudragit RS

    films. They showed that these organic acids (in dissociated andundissociated form) affect the film properties. Thus, the ob-

    served plasticizing effects can either be attributed to the anions,

    cations or both (it was beyond the scope of this study to dif-

    ferentiate between the different species).

    An important practical application of Eqs. (10)(12) is the

    possibility to predict the diffusion coefficient of the drugs in

    Eudragit RS for arbitrary initial drug contents in a quantitative

    way. Knowing these values, Eqs. (6)(8) can be used to calculate

    the resulting drug release kinetics. Fig. 8 shows as an example the

    theoretically predicted release patterns from ibuprofen-loaded

    Eudragit RS films with an initial drug content of 12.5% w/w and a

    thickness of 112 m (based on a D value of 1.91011

    cm

    2

    /s)(curve). In order to verify the mathematical analysis, the res-

    pective films were prepared in reality and the resulting release

    patterns measured in phosphate buffer pH 7.4. As it can be seen in

    Fig. 8, the obtained experimental results (symbols) are in very

    good agreement with the theoretical predictions, proving the

    validity of the presented mathematical model.

    Fig. 9a shows the theoretically predicted effects of the film

    thickness on chlorpheniramine maleate release from Eudragit

    RS-based films with an initial drug content of 15% (w/w).

    Clearly, the variation of the film thickness is a very efficient tool

    to alter the resulting drug release patterns (an increase in thick-

    ness leads to increased diffusion pathway lengths and, thus,

    decreased relative drug release rates). Importantly, the presentedmathematical theory is able to quantitatively predict these

    effects. In addition, Eqs. (6)(12) can be used to theoretically

    predict the impact of the initial drug content on the resulting

    release profiles. In Fig. 9b the simulated release patterns of

    chlorpheniramine maleate from Eudragit RS films with an initial

    drug content of 2.512.5% (w/w) are shown as an example.

    Thus, the required system composition for a desired release rate

    can be predicted. A further interesting application of the

    presented mathematical theory is the possibility to predict the

    required device design (geometry and composition) to achieve

    the same drug release patterns for different types of drugs. As an

    example Fig. 9c shows the release profiles of metoprolol tartrate,chlorpheniramine maleate and ibuprofen from Eudragit RS-

    based films with an initial drug content of 5% (w/w). At film

    thicknesses of 150, 85 and 12 m, the resulting release rates are

    virtually overlapping, despite of the tremendous differences in

    film permeability for these drugs. This type of calculations can

    be very useful for the optimization of controlled drug delivery

    systems containing different types of drugs.

    6. Conclusions

    Metoprolol tartrate, chlorpheniramine maleate and ibuprofen

    are efficient plasticizers for Eudragit RS as shown by the

    thermal and mechanical properties of drug-loaded polymeric

    films. Importantly, mass transport in these systems is primarily

    controlled by pure diffusion. Interestingly, exponential relation-

    ships between the drug diffusivity and the initial drug loading

    could be established. Based on this knowledge and adequate

    analytical solutions of Fick's second law of diffusion, the effects

    of the geometry, dimension and composition of the device on

    the resulting release patterns can be quantitatively predicted.Importantly, also significant drugpolymer interactions can be

    taken into account by the presented mathematical analysis,

    which can be extended to other device geometries, e.g. coated

    pellets and tablets. Thus, the obtained knowledge can help to

    facilitate the development and optimization of novel controlled

    drug delivery systems.

    Acknowledgements

    The authors are grateful for the support of this work by

    French Association for Cancer Research ARC (Association

    pour la Recherche sur le Cancer

    : postdoctoral fellowship forFlorence Siepmann) and by the CAMPLP (Caisse d'assur-

    ance maladie des professions liberales-Provinces).

    References

    [1] P. Schultz, P. Kleinebudde, A new multiparticulate delayed release system:

    Part I. Dissolution properties and release mechanism, J. Control. Release

    47 (1997) 181189.

    [2] P. Schultz, I. Tho, P. Kleinebudde, A new multiparticulate delayed release

    system: Part II. Coating formulation and properties of free films, J. Control.

    Release 47 (1997) 191199.

    [3] J. Siepmann, F. Lecomte, R. Bodmeier, Diffusion-controlled drug delivery

    systems: calculation of the required composition to achieve desired release

    profiles, J. Control. Release 60 (1999) 379389.

    [4] J.C. Gutierrez-Rocca, J.W. McGinity, Influence of water-soluble and

    insoluble plasticizers on the physical and mechanical properties of acrylic

    resin copolymers, Int. J. Pharm. 103 (1994) 293301.

    [5] S.E. Frisbee, J.W. McGinity, Influenceof non-ionicsurfactants on the physical

    and chemical properties of a biodegradable pseudolatex, Eur. J. Pharm.

    Biopharm. 40 (1994) 355363.

    [6] P.B.O'Donnell, C.B. Wu, J. Wang, B. Oshlach, M. Chasin, R. Bodmeier, J.W.

    McGinity, An aqueous based pseudolatex of zein protein for film coating of

    solid dosage forms, Eur. J. Pharm. Biopharm. 43 (1997) 8389.

    [7] C. Wu, J.W. McGinity, Influence of relative humidity on the mechanical and

    drug release properties of theophylline pellets coated withan acrylicpolymer

    containing methylparaben as a non-traditional plasticizer, Eur. J. Pharm.

    Biopharm. 50 (2000) 277284.

    [8] C. Aitken-Nichol, F. Zhang, J.W. McGinity, Hot melt extrusion of acrylic

    films, Pharm. Res. 13 (1996) 804808.

    [9] M.M. Crowley, A. Fredersdorf, B. Schroeder, S. Kucera, S. Prodduturi, M.A.

    Repka, J.W. McGinity, The influence of guaifenesin and ketoprofen on the

    properties of hot-melt extruded polyethylene oxide films, Eur. J. Pharm. Sci.

    22 (2004) 409418.

    [10] M.R. Jenquin, S.M. Liebowitz, R.E. Sarabia, J.W. McGinity, Physical and

    chemical factors influencing the release of drugs from acrylic resin films,

    J. Pharm. Sci. 79 (1990) 811816.

    [11] Y. Zhu, N.H. Shah, A.W. Malick, M.H. Infeld, J.W. McGinity, Solid-state

    plasticization of an acrylic polymer with chlorpheniramine maleate and

    triethyl citrate, Int. J. Pharm. 241 (2002) 301310.

    [12] C. Wu, J.W. McGinity, Non-traditional plasticization of polymeric films,

    Int. J. Pharm. 177 (1999) 1527.

    [13] C. Wu, J.W. McGinity, Influence of ibuprofen as a solid-state plasticizer in

    Eudragit RS 30D on the physicochemical properties of coated beads,

    AAPS PharmSciTech 2 (2001) (article 24).

    305F. Siepmann et al. / Journal of Controlled Release 115 (2 006) 298306

  • 7/30/2019 Drugs acting as plasticizers in polymeric systems a quantitative treatment.pdf

    9/9

    [14] J. Crank, The Mathematics of Diffusion, 2nd Ed., Clarendon Press,

    Oxford, 1975.

    [15] J. Crank, G.S. Park, Methods of measurement, in: J. Crank, G.S. Park

    (Eds.), Diffusion in Polymers, Academic Press, London, 1968, pp. 139.

    [16] L.T. Fan, S.K. Singh, Controlled Release: A Quantitative Treatment,

    Springer-Verlag, Berlin, 1989.

    [17] H.S. Carslaw, J.C. Jaeger, Conduction of Heat in Solids, Clarendon Press,

    Oxford, 1959.[18] J.M. Vergnaud, Controlled Drug Release of Oral Dosage Forms, Ellis

    Horwood, Chichester, 1993.

    [19] C. De Brabander, G. Van den Mooter, C. Vervaet, J.P. Remon,

    Characterization of ibuprofen as a nontraditional plasticizer of ethyl

    cellulose, J. Pharm. Sci. 91 (2002) 16781685.

    [20] M. Singh, J.A. Lumpkin, J. Rosenblatt, Mathematical modeling of drug

    release from hydrogel matrices via a diffusion coupled with desorption

    mechanism, J. Control. Release 32 (1994) 1725.

    [21] S. Narisawa, M. Nagata, C. Danyoshi,H. Yoshino, K. Murata, Y. Hirakawa,

    K. Noda, An organic-induced sigmoidal release system for oral controlled-

    release preparations, Pharm. Res. 11 (1994) 111116.

    [22] S. Narisawa, M. Nagata, Y. Hirakawa, M. Kobayashi, H. Yoshino, An

    organic-induced sigmoidal release system for oral controlled-releasepreparations. 2. Permeability enhancement of Eudragit RS coating led by

    the physicochemical interactions with organic acid, J. Pharm. Sci. 85

    (1996) 184188.

    306 F. Siepmann et al. / Journal of Controlled Release 115 (2006) 298306